To study non-small cell lung cancer harbouring non-resistant uncommon EGFR mutations: Mutation patterns, effectiveness of epidermal growth factor receptor-tyrosine kinase inhibitors and prognostic factors
Latest Information Update: 22 Aug 2019
At a glance
Most Recent Events
- 22 Aug 2019 New trial record
- 16 Aug 2019 Results assessing the effectiveness of EGFR-TKIs as the first-line therapy in patients with NSCLC published in the European Journal of Cancer